Trial intelligence / Profile preview

Targeted Fusion Biopsy of the Prostate

NCT02744534Phase 2Completed

Sponsor
Emory University
Start
Nov 2015
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by Emory University. Started Nov 2015; status: completed.

02

Drugs

fluciclovine f 18
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT02744534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02744534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call